These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 15298560)

  • 1. Induction of T 'regulatory' cells by standardized house dust mite immunotherapy: an increase in CD4+ CD25+ interleukin-10+ T cells expressing peripheral tissue trafficking markers.
    Gardner LM; Thien FC; Douglass JA; Rolland JM; O'Hehir RE
    Clin Exp Allergy; 2004 Aug; 34(8):1209-19. PubMed ID: 15298560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased allergen concentration enhances IFN-gamma production by allergic donor T cells expressing a peripheral tissue trafficking phenotype.
    Gardner LM; Spyroglou L; O'Hehir RE; Rolland JM
    Allergy; 2004 Dec; 59(12):1308-17. PubMed ID: 15507100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose allergen stimulation of T cells from house dust mite-allergic subjects induces expansion of IFN-gamma+ T Cells, apoptosis of CD4+IL-4+ T cells and T cell anergy.
    Gardner LM; O'Hehir RE; Rolland JM
    Int Arch Allergy Immunol; 2004 Jan; 133(1):1-13. PubMed ID: 14646373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CD4+CD25+Foxp3+IL-10+ T cells in HDM-allergic asthmatic children with or without SIT.
    Wei W; Liu Y; Wang Y; Zhao Y; He J; Li X; Shen K
    Int Arch Allergy Immunol; 2010; 153(1):19-26. PubMed ID: 20357481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children.
    Ajduk J; Marinic I; Aberle N; Rabatic S; Gagro A
    Ann Allergy Asthma Immunol; 2008 Apr; 100(4):314-22. PubMed ID: 18450115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responses of CD4(+) CD25(+) Foxp3(+) and IL-10-secreting type I T regulatory cells to cluster-specific immunotherapy for allergic rhinitis in children.
    Lou W; Wang C; Wang Y; Han D; Zhang L
    Pediatr Allergy Immunol; 2012 Mar; 23(2):140-9. PubMed ID: 22192331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
    O'Brien RM; Byron KA; Varigos GA; Thomas WR
    Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequencies of circulating CD4+CD25+CD127low cells in atopics are altered by bronchial allergen challenge.
    Moniuszko M; Kowal K; Zukowski S; Dabrowska M; Bodzenta-Lukaszyk A
    Eur J Clin Invest; 2008 Mar; 38(3):201-4. PubMed ID: 18257784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
    Wang LH; Lin YH; Yang J; Guo W
    Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation.
    Bohle B; Kinaciyan T; Gerstmayr M; Radakovics A; Jahn-Schmid B; Ebner C
    J Allergy Clin Immunol; 2007 Sep; 120(3):707-13. PubMed ID: 17681368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy.
    Jutel M; Akdis M; Budak F; Aebischer-Casaulta C; Wrzyszcz M; Blaser K; Akdis CA
    Eur J Immunol; 2003 May; 33(5):1205-14. PubMed ID: 12731045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
    Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
    Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to house dust mite allergen (Der p 1), cord blood T cell phenotype and cytokine production and atopic dermatitis during the first year of life.
    Hagendorens MM; Ebo DG; Bridts CH; Van de Water L; De Clerck LS; Stevens WJ
    Pediatr Allergy Immunol; 2004 Aug; 15(4):308-15. PubMed ID: 15305939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
    Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
    Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of IL-10+ CD4+ CD25+ regulatory T cells with decreased NF-κB expression during immunotherapy.
    Tsai YG; Chiou YL; Chien JW; Wu HP; Lin CY
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 2):e166-73. PubMed ID: 19682278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. House dust mite-specific T cells in healthy non-atopic children.
    Bullens DM; De Swerdt A; Dilissen E; Kasran A; Kroczek RA; Cadot P; Casaer P; Ceuppens JL
    Clin Exp Allergy; 2005 Dec; 35(12):1535-41. PubMed ID: 16393318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House dust mite sublingual immunotherapy: the role for transforming growth factor-beta and functional regulatory T cells.
    O'Hehir RE; Gardner LM; de Leon MP; Hales BJ; Biondo M; Douglass JA; Rolland JM; Sandrini A
    Am J Respir Crit Care Med; 2009 Nov; 180(10):936-47. PubMed ID: 19696440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report.
    Ciprandi G; Fenoglio D; Cirillo I; Vizzaccaro A; Ferrera A; Tosca MA; Puppo F
    Ann Allergy Asthma Immunol; 2005 Jul; 95(1):38-44. PubMed ID: 16095140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.